Literature DB >> 19282471

RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.

Konasale M Prasad1, Laura Almasy, Ruben C Gur, Raquel E Gur, Michael Pogue-Geile, Kodavali V Chowdari, Michael E Talkowski, Vishwajit L Nimgaonkar.   

Abstract

Polymorphisms of the gene encoding the regulator of G protein signaling, subtype 4 (RGS4), may be associated with schizophrenia. Among first-episode schizophrenia patients, they are also associated with dorsolateral prefrontal cortex (DLPFC) volume. The DLPFC is a key region that regulates heritable cognitive functions implicated in schizophrenia pathogenesis. To further understand the relationship of RGS4 variants to schizophrenia, we examined their associations with cognitive functions among schizophrenia patients and their relatives. We analyzed 31 multiplex, multigenerational Caucasian families with schizophrenia recruited on the basis of 2 affected first-degree relatives. All participants underwent a computerized neurocognitive battery that evaluates accuracy and speed (response time) of performance on abstraction/mental flexibility; attention; verbal, spatial, and face memory; and spatial ability. "Tag" single-nucleotide polymorphisms (SNPs) representing common polymorphisms were genotyped. Measured genotype analyses accounting for family relationships were performed using Sequential Oligogenic Linkage Analysis Routines. SNPs rs10917670 ("SNP1") and rs951439 ("SNP7") were associated with face memory speed (P = .0003) at a significance level that survived Bonferroni correction (P = .039). The same SNPs have earlier been reported to be associated with schizophrenia. There also were uncorrected associations with rs10917670 ("SNP1") and rs951439 ("SNP7") on face memory efficiency (P = .03) and verbal memory efficiency (P = 0.02), rs28757217 on abstraction/mental flexibility speed (P = .02) and verbal memory efficiency (P = .03), SNP18 (rs2661319) on spatial memory accuracy (P = 0.02) and face memory speed (P = .03). RGS4 polymorphisms are associated with variations in cognitive functions and contribute a small but statistically significant proportion of variance in a family-based sample.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282471      PMCID: PMC2930339          DOI: 10.1093/schbul/sbp002

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  41 in total

1.  Dopamine, cognitive control, and schizophrenia: the gating model.

Authors:  T S Braver; J D Cohen
Journal:  Prog Brain Res       Date:  1999       Impact factor: 2.453

Review 2.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

Authors:  Beth E Snitz; Angus W Macdonald; Cameron S Carter
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

3.  DISC1 and neurocognitive function in schizophrenia.

Authors:  Katherine E Burdick; Colin A Hodgkinson; Philip R Szeszko; Todd Lencz; Jenny M Ekholm; John M Kane; David Goldman; Anil K Malhotra
Journal:  Neuroreport       Date:  2005-08-22       Impact factor: 1.837

4.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.

Authors:  K Mirnics; F A Middleton; G D Stanwood; D A Lewis; P Levitt
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

5.  Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia.

Authors:  Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur
Journal:  Am J Psychiatry       Date:  2007-05       Impact factor: 18.112

6.  Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians.

Authors:  Janet L Sobell; Christian Richard; Donna A Wirshing; Leonard L Heston
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

7.  A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia.

Authors:  Mario Fioravanti; Olimpia Carlone; Barbara Vitale; Maria Elena Cinti; Linda Clare
Journal:  Neuropsychol Rev       Date:  2005-06       Impact factor: 7.444

8.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

9.  Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients.

Authors:  K M R Prasad; K V Chowdari; V L Nimgaonkar; M E Talkowski; D A Lewis; M S Keshavan
Journal:  Mol Psychiatry       Date:  2005-02       Impact factor: 15.992

10.  Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil Bamne; Joel Wood; Michael E Talkowski; Karoly Mirnics; Pat Levitt; David A Lewis; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-05-21       Impact factor: 9.306

View more
  7 in total

1.  Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.

Authors:  Konasale M Prasad; Shaun M Eack; Matcheri S Keshavan; Robert H Yolken; Satish Iyengar; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

2.  Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk.

Authors:  Mark Z Kos; Melanie A Carless; Juan Peralta; August Blackburn; Marcio Almeida; David Roalf; Michael F Pogue-Geile; Konasale Prasad; Ruben C Gur; Vishwajit Nimgaonkar; Joanne E Curran; Ravi Duggirala; David C Glahn; John Blangero; Raquel E Gur; Laura Almasy
Journal:  Schizophr Bull       Date:  2015-09-24       Impact factor: 9.306

Review 3.  Synaptic changes in the brain of subjects with schizophrenia.

Authors:  Gábor Faludi; Károly Mirnics
Journal:  Int J Dev Neurosci       Date:  2011-03-05       Impact factor: 2.457

Review 4.  Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity.

Authors:  Kyle J Gerber; Katherine E Squires; John R Hepler
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

5.  Gene expression alterations in bipolar disorder postmortem brains.

Authors:  Haiming Chen; Nulang Wang; Xin Zhao; Christopher A Ross; K Sue O'Shea; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2013-01-30       Impact factor: 6.744

6.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Authors:  M Ayalew; H Le-Niculescu; D F Levey; N Jain; B Changala; S D Patel; E Winiger; A Breier; A Shekhar; R Amdur; D Koller; J I Nurnberger; A Corvin; M Geyer; M T Tsuang; D Salomon; N J Schork; A H Fanous; M C O'Donovan; A B Niculescu
Journal:  Mol Psychiatry       Date:  2012-05-15       Impact factor: 15.992

7.  Heritable anisotropy associated with cognitive impairments among patients with schizophrenia and their non-psychotic relatives in multiplex families.

Authors:  K M Prasad; J Gertler; S Tollefson; J A Wood; D Roalf; R C Gur; R E Gur; L Almasy; M F Pogue-Geile; V L Nimgaonkar
Journal:  Psychol Med       Date:  2020-09-03       Impact factor: 10.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.